Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ziqing Zeng

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Pharmaceutical Science Advances|January 19, 2026
Progresses in the study of polysaccharide from medicinal plants of the Asclepiadaceae familyHe Xiao, Ziqing Zeng, Wenjie Jiang
Cancer Biology & Medicine|December 10, 2020
Exhausted T cells and epigenetic statusZiqing Zeng, Feng Wei, Xiubao Ren
Frontiers in Molecular Biosciences|August 9, 2021
TIM-3 and CEACAM1 are Prognostic Factors in Head and Neck Squamous Cell CarcinomaFan Yang, Ziqing Zeng, Jing Li, et al.
Frontiers in Oncology|January 9, 2019
PD-1/PD-L1 Axis, Rather Than High-Mobility Group Alarmins or CD8+ Tumor-Infiltrating Lymphocytes, Is Associated With Survival in Head and Neck Squamous Cell Carcinoma Patients Who Received Surgical ResectionFan Yang, Ziqing Zeng, Jing Li, et al.
Oncoimmunology|October 26, 2020
Significantly different immunological score in lung adenocarcinoma and squamous cell carcinoma and a proposal for a new immune staging systemZiqing Zeng, Fan Yang, Yunliang Wang, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 7, 2023
[<sup>177</sup>Lu]Lu-labeled anti-claudin-18.2 antibody demonstrated radioimmunotherapy potential in gastric cancer mouse xenograft modelsZiqing Zeng, Liqiang Li, Jinping Tao, et al.
Journal of Leukocyte Biology|September 8, 2022
The prognostic value of a 4-factor neoimmunologic score system in non-small cell lung cancerFan Yang, Ziqing Zeng, Yuan Li, et al.
Translational Lung Cancer Research|July 18, 2020
Feasibility of sleeve lobectomy after neo-adjuvant chemo-immunotherapy in non-small cell lung cancerYulong Chen, Lianmin Zhang, Bo Yan, et al.
Scientific Reports|December 7, 2025
Influence maximization under the linear threshold model on a CMOS Ising solverZiqing Zeng, S Ramprasath, Hüsrev Cılasun, et al.
Oncoimmunology|September 17, 2020
Expression signature, prognosis value, and immune characteristics of Siglec-15 identified by pan-cancer analysisBaihui Li, Bailu Zhang, Xuezhou Wang, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Pharmaceutical Science Advances|January 19, 2026
Progresses in the study of polysaccharide from medicinal plants of the Asclepiadaceae familyHe Xiao, Ziqing Zeng, Wenjie Jiang
Cancer Biology & Medicine|December 10, 2020
Exhausted T cells and epigenetic statusZiqing Zeng, Feng Wei, Xiubao Ren
Frontiers in Molecular Biosciences|August 9, 2021
TIM-3 and CEACAM1 are Prognostic Factors in Head and Neck Squamous Cell CarcinomaFan Yang, Ziqing Zeng, Jing Li, et al.
Frontiers in Oncology|January 9, 2019
PD-1/PD-L1 Axis, Rather Than High-Mobility Group Alarmins or CD8+ Tumor-Infiltrating Lymphocytes, Is Associated With Survival in Head and Neck Squamous Cell Carcinoma Patients Who Received Surgical ResectionFan Yang, Ziqing Zeng, Jing Li, et al.
Oncoimmunology|October 26, 2020
Significantly different immunological score in lung adenocarcinoma and squamous cell carcinoma and a proposal for a new immune staging systemZiqing Zeng, Fan Yang, Yunliang Wang, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 7, 2023
[<sup>177</sup>Lu]Lu-labeled anti-claudin-18.2 antibody demonstrated radioimmunotherapy potential in gastric cancer mouse xenograft modelsZiqing Zeng, Liqiang Li, Jinping Tao, et al.
Journal of Leukocyte Biology|September 8, 2022
The prognostic value of a 4-factor neoimmunologic score system in non-small cell lung cancerFan Yang, Ziqing Zeng, Yuan Li, et al.
Translational Lung Cancer Research|July 18, 2020
Feasibility of sleeve lobectomy after neo-adjuvant chemo-immunotherapy in non-small cell lung cancerYulong Chen, Lianmin Zhang, Bo Yan, et al.
Scientific Reports|December 7, 2025
Influence maximization under the linear threshold model on a CMOS Ising solverZiqing Zeng, S Ramprasath, Hüsrev Cılasun, et al.
Oncoimmunology|September 17, 2020
Expression signature, prognosis value, and immune characteristics of Siglec-15 identified by pan-cancer analysisBaihui Li, Bailu Zhang, Xuezhou Wang, et al.
Pageof 3